Long-lasting HIV prevention drug too slow to reach Africa, activists say science.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from science.org Daily Mail and Mail on Sunday newspapers.
The South African Health Products Regulatory Authority recently approved the use of the monthly dapivirine vaginal ring for women 18 years and older to reduce the risk of HIV infection. Spotlight looks at the evidence for the ring’s efficacy and asks what plans there are for making it availab.
First long-acting HIV prevention product designed specifically for womenApproval paves the way for the monthly ring’s introduction Nearly two-thirds of new adult HIV infections in South Africa occur among womenSILVER SPRING, Md. (March 11, 2022) The nonprofit International Partnership for Microbicides (IPM) today announced that the monthly dapivirine vaginal ring received
There is no time to waste in planning the South African rollout of cabotegravir, the long-lasting antiretroviral injection approved for use in the United States in December 2021.